Evidence map›Paper›PMID 27003156›Full record

ArticleVirchows Archiv : an international journal of pathology2016

Serous tubal intraepithelial carcinoma, chronic fallopian tube injury, and serous carcinoma development.

Karin Malmberg, Charlotta Klynning, Angelique Flöter-Rådestad, Joseph W Carlson

Abstract read
PubMed Publisher
In one paragraph

Article in Virchows Archiv : an international journal of pathology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
3.1field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it, 12 citations in OpenAlex.

  1. Recommendations for diagnosing STIC: a systematic review and meta-analysis.Virchows Archiv : an international journal of pathology · 2022
    Pooled it
  2. Review
  3. Review
  4. Article
  5. Pathogenesis and heterogeneity of ovarian cancer.Current opinion in obstetrics & gynecology · 2017
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Karin MalmbergDepartment of Oncology-Pathology, Karolinska Institutet and Department of Pathology, Karolinska University Hospital, Stockholm, Sweden.
Charlotta KlynningDepartment of Women's and Children's Health, Karolinska Institutet, and Department of Gynecology, Karolinska University Hospital, Stockholm, Sweden.
Angelique Flöter-RådestadDepartment of Women's and Children's Health, Karolinska Institutet, and Department of Gynecology, Karolinska University Hospital, Stockholm, Sweden.
Joseph W CarlsonDepartment of Oncology-Pathology, Karolinska Institutet and Department of Pathology, Karolinska University Hospital, Stockholm, Sweden. joseph.carlson@ki.se.
Karolinska Institutet · SEKarolinska University Hospital · SE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Ovarian carcinoma is the deadliest gynecological malignancy. Previous studies have suggested that the fallopian tube may be the primary site for high-grade serous carcinoma. In prophylactic salpingo-oophorectomies from women with hereditary high risk for ovarian cancer, precursors can be assessed prior to onset and studied as a model for serous cancer precursor lesions. Epidemiologic studies indicate that carcinogenesis may be a result of chronic fallopian tube injury. The aims of this study were to (1) to examine the incidence of serous tubal intraepithelial carcinoma (STIC) in relation to other clinical parameters and (2) to evaluate whether chronic fallopian tube injury was related to cancer development. This study enrolled 101 women, comprising the following three groups: hereditary (n = 60), sporadic serous cancer (n = 18; endometrial cancers were excluded), and control (n = 23). The cases were histologically examined and clinical risk factors were collected. The histological changes were compared between different patients and correlated to clinical risk factors. STICs were identified primarily on the fallopian tube fimbria. The incidence of STIC was 3 % in the hereditary patients. In sporadic serous cancer cases, 61 % were associated with STIC and tubal carcinoma (p < 0.001). No differences in tubal injury or inflammation were seen when comparing the sporadic serous cancer group and the control group or within the hereditary group. STIC and invasive cancer were seen more often in the older patients than in the younger patients (p = 0.528). This small study, no correlation with chronic tubal injury or inflammation was identified.

Indexed as

AdenocarcinomaAdultAged, 80 and overCarcinoma in SituChronic DiseaseCystadenocarcinoma, SerousFallopian Tube NeoplasmsFallopian TubesFemaleHumansMiddle AgedOvarian NeoplasmsCarcinoma in situFallopian tubesInflammationOvarySerous cystadenocarcinoma

Identifiers

PMID27003156
OpenAlexW2306813523

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.